Jean Santos

发表

A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury

Jamie L. Marshall, M. Kost-Alimova, S. Alper, 2020, Cell Reports Medicine.

A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic

Jamie L. Marshall, L. Ronco, S. Alper, 2020, bioRxiv.